Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
Data(s) |
2008
|
---|---|
Identificador |
https://serval.unil.ch/?id=serval:BIB_BB75058D37D9 isbn:1468-2060[electronic], 0003-4967[linking] pmid:17875547 doi:10.1136/ard.2007.075895 isiid:000253443600006 |
Idioma(s) |
en |
Fonte |
Annals of the Rheumatic Diseases, vol. 67, no. 3, pp. 309-314 |
Palavras-Chave | #Adolescent; Antirheumatic Agents/therapeutic use; Arthritis, Juvenile Rheumatoid/drug therapy; Arthritis, Juvenile Rheumatoid/physiopathology; Child; Child, Preschool; Disability Evaluation; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents/therapeutic use; Male; Methotrexate/therapeutic use; Quality of Life; Recovery of Function; Severity of Illness Index; Treatment Outcome |
Tipo |
info:eu-repo/semantics/article article |